MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $52.76
2.70 (5.39%) Open Price: 50.44

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(07/31/25) $50.44
(08/01/25) $50.06
(08/01/25) (Qty.)957,596
(07/31/25) $49.46
(07/31/25) $51.59
(07/27/25) $46.12
(07/20/25) $57.45
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing